IN RE ROSUVASTATIN CALCIUM PATENT LITIGATION.
ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs-Appellees,
v.
AUROBINDO PHARMA LIMITED, Defendant-Appellant, AND
MYLAN PHARMACEUTICALS INC., Defendant-Appellant, AND
APOTEX CORP., Defendant-Appellant, AND
COBALT PHARMACEUTICALS INC. AND COBALT LABORATORIES INC., Defendants-Appellants, AND
SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendant-Appellant, AND
TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant, AND
PAR PHARMACEUTICAL, INC., Defendant-Appellant, AND
SANDOZ, INC., Defendant.
United States Court of Appeals, Federal Circuit.https://leagle.com/images/logo.png
STEVEN A. MADDOX , Knobbe, Martens, Olson & Bear, LLP, of Washington, DC, argued for defendant-appellant. With him on the brief were PAYSON LEMEILLEUR and JARED BUNKER , Knobbe, Martens, Olson & Bear, LLP, of Irvine, California.
Opinion of the court filed by NEWMAN. Concurring opinion filed by PLAGER. Dissenting opinion filed by MAYER.
United States Court of Appeals, Federal Circuit.
NEWMAN, Circuit Judge.
This patent litigation arises under the Hatch-Waxman Act, 21 U.S.C. §355, whereby producers of generic pharmaceutical products are authorized to challenge the patent status of a federally registered and approved drug product, before the generic producer has obtained approval to sell its counterpart of the approved product. The generic litigant who succeeds in eliminating the drug patent is granted a 180-day period of exclusivity against...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.